Morgan Stanley Feels Confident About Express Scripts Holding Ahead of Investor Day

In a report published Tuesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating and $76.00 price target on

. In the report, Morgan Stanley noted, “ESRX will be hosting its first investor day post the MHS acquisition and introducing FY14 guidance and its new CFO Cathy Smith. With shares up ~9.3% year-to-date outperforming the market (+980 bps) and our coverage (+670 bps) expectations have been building up for ESRX to deliver mid-teens growth over next 12 to 18 month as the generic pipeline is scheduled to accelerate in that time period.” Express Scripts Holding Company closed on Friday at $76.75.